STATE STREET CORP - ARGOS THERAPEUTICS INC ownership

Quarter-by-quarter ownership
STATE STREET CORP ownership history of ARGOS THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$1,000
-50.0%
11,9000.0%0.00%
Q3 2017$2,000
-50.0%
11,9000.0%0.00%
Q2 2017$4,000
-95.1%
11,900
-93.5%
0.00%
Q1 2017$82,000
-90.6%
184,194
+3.8%
0.00%
Q4 2016$870,000
+10.5%
177,494
+11.7%
0.00%
Q3 2016$787,000
+6.2%
158,869
+31.3%
0.00%
Q2 2016$741,000
+179.6%
120,996
+356.5%
0.00%
Q1 2014$265,00026,5070.00%
Other shareholders
ARGOS THERAPEUTICS INC shareholders Q3 2023
NameSharesValueWeighting ↓
AWM Investment Company, Inc. 719,305$3,489,0000.68%
WALL STREET ASSOCIATES 257,900$1,243,0000.24%
WASATCH ADVISORS LP 2,298,711$11,149,0000.15%
Pinnacle Summer Investments, Inc. 90,733$507,0000.09%
ALTRINSIC GLOBAL ADVISORS LLC 212,505$1,024,0000.02%
STONERIDGE INVESTMENT PARTNERS LLC 27,024$130,0000.02%
Alyeska Investment Group, L.P. 144,025$694,0000.01%
VANGUARD GROUP INC 4,921,822$180,983,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 40,000$194,0000.00%
CAISSE DE DEPOT ET PLACEMENT DU QUEBEC 317,900$1,542,0000.00%
View complete list of ARGOS THERAPEUTICS INC shareholders